For patients with rheumatic disease and hepatitis C infection: the end of interferon.
about
Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registry.New insights into HCV-related rheumatologic disorders: A review.HCV Treatments and Their Integration Into Rheumatology.Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.Efficacy and safety of sofosbuvir-based, interferon-free therapy : The Management of rheumatologic extrahepatic manifestations associated with chronic hepatitis C virus infection.Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice.
P2860
For patients with rheumatic disease and hepatitis C infection: the end of interferon.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
For patients with rheumatic disease and hepatitis C infection: the end of interferon.
@en
type
label
For patients with rheumatic disease and hepatitis C infection: the end of interferon.
@en
prefLabel
For patients with rheumatic disease and hepatitis C infection: the end of interferon.
@en
P2860
P1433
P1476
For patients with rheumatic disease and hepatitis C infection: the end of interferon
@en
P2093
Leonard H Calabrese
P2860
P304
P356
10.1136/RMDOPEN-2014-000008
P577
2015-02-18T00:00:00Z